Recent News

• 05.15.2025 - Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
• 03.31.2025 - Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update
• 03.05.2025 - Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
• 02.03.2025 - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Recent Filings

• 05.07.2025 - EX-99.1 EX-99.1
• 05.07.2025 - 8-K Current report
• 04.22.2025 - 8-K Current report
• 04.09.2025 - 8-K Current report
• 04.09.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.04.2025 - 3 Initial statement of beneficial ownership of securities
• 02.20.2025 - 8-K Current report